ONKURE THERAPEUTICS, INC. Earnings Per Share (Basic)
ONKURE THERAPEUTICS, INC. (OKUR) reported Earnings Per Share (Basic) of -$0.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- ONKURE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.31.
- ONKURE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$1.11.
- ONKURE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.99.
- ONKURE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.09.
- ONKURE THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$4.40.
- ONKURE THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$15.28.
- ONKURE THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$124.41.
- ONKURE THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$2.12.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.31 10-Q · filed 2026-08-04 | -$0.96 10-Q · filed 2026-08-04 | -$1.71 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$2.59 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2026-03-31 | -$1.11 10-Q · filed 2026-05-05 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$3.19 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$4.33 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-12-31 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$2.08 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$3.22 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$4.40 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$1.09 10-Q · filed 2025-11-06 | -$2.23 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$3.41 10-Q · filed 2025-11-06 | -$4.76 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-06-30 | -$1.14 10-Q · filed 2026-08-04 | -$2.33 10-Q · filed 2026-08-04 | -$3.68 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$6.02 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2025-03-31 | -$1.19 10-Q · filed 2026-05-05 | -$2.54 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$5.07 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$8.78 derived: net income ÷ weighted average shares · filed 2026-08-04 | ||||
| 2024-12-31 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$4.41 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$9.60 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$15.28 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$36.55 10-Q · filed 2025-11-06 | -$1.10 10-Q · filed 2024-11-07 | -$81.36 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$111.77 10-Q · filed 2025-11-06 | -$5.23 10-Q · filed 2024-11-07 | $9.78 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||
| 2024-06-30 | -$44.82 10-Q · filed 2025-08-12 | -$0.16 10-Q · filed 2024-08-13 | -$75.22 10-Q · filed 2025-08-12 | -$0.41 10-Q · filed 2024-08-13 | $2.16 derived: net income ÷ weighted average shares · filed 2025-11-06 | $25.83 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||
| 2024-03-31 | -$30.37 10-Q · filed 2025-05-06 | -$0.25 10-Q · filed 2024-05-07 | -$2.41 derived: net income ÷ weighted average shares · filed 2025-11-06 | $7.50 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$4.55 derived: net income ÷ weighted average shares · filed 2025-11-06 | |||
| 2023-12-31 | -$2.38 derived: net income ÷ weighted average shares · filed 2025-03-10 | $0.31 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$2.35 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$124.41 10-K · filed 2025-03-10 | -$2.52 10-K · filed 2024-03-28 | |||
| 2023-09-30 | -$5.68 10-Q · filed 2024-11-07 | -$0.57 10-Q · filed 2023-11-13 | -$2.31 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$18.11 10-Q · filed 2024-11-07 | -$1.81 10-Q · filed 2023-11-13 | -$3.24 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||
| 2023-06-30 | -$0.65 10-Q · filed 2024-08-13 | -$1.25 10-Q · filed 2024-08-13 | -$1.81 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.35 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2023-03-31 | -$0.60 10-Q · filed 2024-05-07 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.69 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.19 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2022-12-31 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.08 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.59 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$2.12 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$0.53 10-Q · filed 2023-11-13 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.57 10-Q · filed 2023-11-13 | -$2.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.50 10-Q · filed 2023-08-10 | -$1.04 10-Q · filed 2023-08-10 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.99 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-03-31 | -$0.53 10-Q · filed 2023-05-11 | -$0.97 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.49 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2021-12-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$0.95 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$1.39 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$2.19 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | -$0.52 10-Q · filed 2022-11-08 | -$0.96 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.82 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | -$0.43 10-Q · filed 2022-08-09 | -$1.40 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | -$3.48 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | -$9.60 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |